scispace - formally typeset
W

William M. Gwinn

Researcher at Duke University

Publications -  9
Citations -  681

William M. Gwinn is an academic researcher from Duke University. The author has contributed to research in topics: Adjuvant & Chemokine. The author has an hindex of 8, co-authored 8 publications receiving 633 citations. Previous affiliations of William M. Gwinn include Washington University in St. Louis.

Papers
More filters
Journal ArticleDOI

Extracellular Cyclophilins Contribute to the Regulation of Inflammatory Responses

TL;DR: These findings are the first to demonstrate the significant contribution of cyclophilin-CD147 interactions to inflammatory responses and provide a potentially novel approach for reducing inflammation-mediated diseases.
Journal ArticleDOI

Novel Approach to Inhibit Asthma-Mediated Lung Inflammation Using Anti-CD147 Intervention

TL;DR: It is proposed that extracellular cyclophilins, via interaction with CD147, may contribute to the recruitment of leukocytes from the periphery into tissues during inflammatory responses, providing a novel mechanism whereby asthmatic lung inflammation may be reduced.
Journal ArticleDOI

Cytokine requirements for induction of systemic and mucosal CTL after nasal immunization.

TL;DR: IL-1α,IL-12, IL-18, and GM-CSF are critical cytokines for the induction of systemic and mucosal CTL after nasal immunization, and these cytokines may serve as effective adjuvants for nasal vaccine delivery.
Journal ArticleDOI

Hypoxia in the thymus: role of oxygen tension in thymocyte survival.

TL;DR: Analysis of how oxygen tension affects the thymus at the cellular and molecular level suggests that regulatory mechanisms exist to maintain thymic cellular hypoxia in vivo and that oxygen tension may regulate thymocyte survival both in vitro and in vivo.
Journal ArticleDOI

In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity.

TL;DR: Serum collected 24 h after passive transfer had LeTx-neutralizing activity when tested using a standard LeTx neutralization assay, but neutralization titers measured using this assay did not correlate with protection against LeTx challenge, prompting the suggestion that this LeTxneutralization assay may be a more biologically relevant Neutralization assay to predict the in vivo protective capacity of Letx- neutralizing antibodies.